Last reviewed · How we verify

NCT07425327

Validity and Reliability of the Two-minute Step Test in Hemophilia

Not yet recruiting Last updated 20 February 2026
What this trial tests

trial in Hemophilia in 35 participants. Not yet recruiting.

Timeline
25 February 2026
Primary endpoint
25 April 2026
25 June 2026

Quick facts

Lead sponsorHasan Kalyoncu University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment35
Start date25 February 2026
Primary completion25 April 2026
Estimated completion25 June 2026
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Hasan Kalyoncu University

Who can join

Adults 6 to 18, male only, with Hemophilia or Step. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study was to evaluate the psychometric properties of the 2-minute step test in hemophilia patients, assess its intra-rater and inter-rater reliability, and evaluate its convergent validity and construct validity supported by measurements of gait, balance, and functionality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hemophilia

Currently open trials in the same condition.

Other Hasan Kalyoncu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07425327.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing